Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Infection with HIV results in an incremental loss of T helper cell (TH) function, which can occur years before CD4 cell numbers are critically reduced and AIDS is diagnosed. All TH function is not affected, however, because B cell activation and hypergammaglobulinema are also characteristic of this period. Recently, in a murine model of AIDS an early loss in production of the CD4 cytokines IL-2 and IFN-gamma was correlated with an increase in the B cell stimulatory cytokines IL-4, IL-5, and IL-10. We therefore assessed the production of IL-4 generated by PBL from HIV-seropositive (HIV+) individuals who did not have AIDS, yet who exhibited different TH functional categories based on their IL-2 production profiles. We observed that the decreases in recall antigen-stimulated IL-2 production were accompanied by an increase in IL-4 production. The loss of recall antigen-stimulated responses in HIV+ individuals could be reversed in vitro by anti-IL-4 antibody. Our results suggest that the TH functions assessed by IL-4 production replace the normally dominant TH function of antigen-stimulated IL-2 production in the progression toward AIDS, and raise the possibility of cytokine cross-regulation in AIDS therapy.

[1]  M. Clerici,et al.  A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Sher,et al.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Sher,et al.  CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. , 1992, Journal of immunology.

[4]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[5]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[6]  F. Finkelman,et al.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. , 1991, Journal of immunology.

[7]  M. Croft,et al.  Helper T‐Cell Subsets: Phenotype, Function and the Role of Lymphokines in Regulating their Development , 1991, Immunological reviews.

[8]  S. Kaufmann,et al.  The role of T-cell subsets and cytokines in the regulation of infection. , 1991, Immunology today.

[9]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[10]  D. Freedman,et al.  Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. , 1991, The Journal of clinical investigation.

[11]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[12]  J. Yagüe,et al.  IL-4 inhibits IL-2 synthesis and IL-2-induced up-regulation of IL-2R alpha but not IL-2R beta chain in CD4+ human T cells. , 1991, Journal of immunology.

[13]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[14]  T. Gajewski,et al.  Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. , 1991, Journal of immunology.

[15]  C. Katlama,et al.  A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity , 1991, European journal of immunology.

[16]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[17]  R. Kurth,et al.  Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro , 1990, European journal of immunology.

[18]  J. Justement,et al.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Miedema,et al.  Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. , 1990, The Journal of clinical investigation.

[20]  M. Clerici,et al.  Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation. , 1990, Journal of immunology.

[21]  M. Clerici,et al.  Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. , 1990, Clinical immunology and immunopathology.

[22]  Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. , 1990, Disease markers.

[23]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[24]  J. Church,et al.  Lymphocyte phenotype does not predict immune function in pediatric patients infected with human immunodeficiency virus type 1. , 1989, The Journal of pediatrics.

[25]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[26]  R. Mittler,et al.  Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. , 1989, Science.

[27]  H. Lyerly,et al.  HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. , 1989, Journal of immunology.

[28]  M. Clerici,et al.  Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. , 1989, The Journal of clinical investigation.

[29]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[30]  Jaap,et al.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. , 1988, The Journal of clinical investigation.

[31]  M. Lederman,et al.  Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. , 1988, The Journal of laboratory and clinical medicine.

[32]  F. Miedema,et al.  Decreased accessory cell function by human monocytic cells after infection with HIV. , 1988, Journal of immunology.

[33]  D. Kaufman,et al.  The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. , 1987, Cellular immunology.

[34]  J V Giorgi,et al.  Early effects of HIV on CD4 lymphocytes in vivo. , 1987, Journal of immunology.

[35]  W. Blattner,et al.  HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. , 1987, Journal of immunology.

[36]  E. Maggi,et al.  Reduced production of interleukin 2 and interferongamma and enhanced helper activity for IgG synthesis by cloned CD4+ T cells from patients with AIDS , 1987, European journal of immunology.

[37]  D. Markovitz,et al.  The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.

[38]  J. Nielsen,et al.  Immunological Studies in the Acquired Immunodeficiency Syndrome , 1986, Scandinavian journal of immunology.

[39]  R. Redfield,et al.  The Walter Reed staging classification for HTLV-III/LAV infection. , 1986, The New England journal of medicine.

[40]  H. Morse,et al.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice , 1985, The Journal of experimental medicine.

[41]  L. Mayer,et al.  Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. , 1984, Science.

[42]  A. Gottlieb,et al.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions. , 1983, The Journal of clinical investigation.